Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ONEOK, Inc. (OKE): Insiders Aren’t Crazy About It

Page 1 of 2

ONEOK, Inc. (NYSE:OKE) was in 16 hedge funds’ portfolio at the end of March. OKE has experienced a decrease in support from the world’s most elite money managers lately. There were 16 hedge funds in our database with OKE positions at the end of the previous quarter.


In the financial world, there are dozens of methods shareholders can use to monitor the equity markets. Two of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite money managers can outclass the market by a superb amount (see just how much).

Equally as integral, positive insider trading sentiment is a second way to break down the marketplace. As the old adage goes: there are a variety of incentives for an upper level exec to drop shares of his or her company, but only one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this method if shareholders understand where to look (learn more here).

Consequently, we’re going to take a peek at the recent action encompassing ONEOK, Inc. (NYSE:OKE).

How have hedgies been trading ONEOK, Inc. (NYSE:OKE)?

At Q1’s end, a total of 16 of the hedge funds we track were long in this stock, a change of 0% from the previous quarter. With hedgies’ sentiment swirling, there exists a few key hedge fund managers who were boosting their holdings meaningfully.

Of the funds we track, Jim Simons’s Renaissance Technologies had the biggest position in ONEOK, Inc. (NYSE:OKE), worth close to $56.1 million, comprising 0.1% of its total 13F portfolio. The second largest stake is held by Mario Gabelli of GAMCO Investors, with a $18.8 million position; 0.1% of its 13F portfolio is allocated to the company. Other peers with similar optimism include David Harding’s Winton Capital Management, Alec Litowitz and Ross Laser’s Magnetar Capital and Israel Englander’s Millennium Management.

Because ONEOK, Inc. (NYSE:OKE) has experienced falling interest from the aggregate hedge fund industry, logic holds that there exists a select few fund managers that decided to sell off their positions entirely at the end of the first quarter. At the top of the heap, Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners dropped the largest investment of all the hedgies we track, worth an estimated $2 million in stock.. Steven Cohen’s fund, SAC Capital Advisors, also said goodbye to its stock, about $1 million worth. These transactions are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about ONEOK, Inc. (NYSE:OKE)?

Insider buying is particularly usable when the company in question has experienced transactions within the past six months. Over the last half-year time frame, ONEOK, Inc. (NYSE:OKE) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to ONEOK, Inc. (NYSE:OKE). These stocks are Integrys Energy Group, Inc. (NYSE:TEG), Sempra Energy (NYSE:SRE), AGL Resources Inc. (NYSE:GAS), Western Gas Equity Partners LP (NYSE:WGP), and EQT Corporation (NYSE:EQT). This group of stocks belong to the gas utilities industry and their market caps are similar to OKE’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!